Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yijiayi Medicine Technology is a China-based contract research organization focused on oncology-related pharmaceutical development support. The company appears to provide one-stop consulting and development services intended to help pharmaceutical partners assess development risk, reduce commercialization risk, and incubate early products. Available public descriptions emphasize support for Chinese pharmaceutical companies seeking to bring products to international markets rather than the development of an internal therapeutic pipeline. Based on the limited public footprint identified, Yijiayi seems to operate primarily as a service provider rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yijiayi Medicine Technology.